Ilyang PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Ilyang PharmaceuticalLtd has a total shareholder equity of ₩263.0B and total debt of ₩84.2B, which brings its debt-to-equity ratio to 32%. Its total assets and total liabilities are ₩459.5B and ₩196.4B respectively. Ilyang PharmaceuticalLtd's EBIT is ₩24.8B making its interest coverage ratio 7.5. It has cash and short-term investments of ₩19.8B.
Key information
32.0%
Debt to equity ratio
₩84.25b
Debt
| Interest coverage ratio | 7.5x |
| Cash | ₩19.76b |
| Equity | ₩263.03b |
| Total liabilities | ₩196.43b |
| Total assets | ₩459.46b |
Recent financial health updates
Is Ilyang PharmaceuticalLtd (KRX:007570) A Risky Investment?
Apr 04
Here's Why Ilyang PharmaceuticalLtd (KRX:007570) Can Manage Its Debt Responsibly
Dec 24
Recent updates
Is Ilyang PharmaceuticalLtd (KRX:007570) A Risky Investment?
Apr 04Should You Be Adding Ilyang PharmaceuticalLtd (KRX:007570) To Your Watchlist Today?
Mar 14Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Shares May Have Slumped 36% But Getting In Cheap Is Still Unlikely
Mar 14Declining Stock and Decent Financials: Is The Market Wrong About Ilyang Pharmaceutical Co.,Ltd (KRX:007570)?
Feb 22Did Business Growth Power Ilyang PharmaceuticalLtd's (KRX:007570) Share Price Gain of 159%?
Feb 01Is Ilyang Pharmaceutical Co.,Ltd's (KRX:007570) Shareholder Ownership Skewed Towards Insiders?
Jan 11Here's Why Ilyang PharmaceuticalLtd (KRX:007570) Can Manage Its Debt Responsibly
Dec 24A Look At The Intrinsic Value Of Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
Dec 06Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 18Financial Position Analysis
Short Term Liabilities: A007570's short term assets (₩159.1B) do not cover its short term liabilities (₩173.7B).
Long Term Liabilities: A007570's short term assets (₩159.1B) exceed its long term liabilities (₩22.8B).
Debt to Equity History and Analysis
Debt Level: A007570's net debt to equity ratio (24.5%) is considered satisfactory.
Reducing Debt: A007570's debt to equity ratio has reduced from 68.6% to 32% over the past 5 years.
Debt Coverage: A007570's debt is well covered by operating cash flow (23%).
Interest Coverage: A007570's interest payments on its debt are well covered by EBIT (7.5x coverage).